HomeTLX • ASX
add
Telix Pharmaceuticals Ltd
Nakaraang pagsara
$15.75
Sakop ng araw
$15.39 - $15.99
Sakop ng taon
$13.30 - $31.97
Market cap
5.27B AUD
Average na Volume
2.23M
P/E ratio
338.19
Dividend yield
-
Primary exchange
ASX
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 195.18M | 58.88% |
Gastos sa pagpapatakbo | 95.47M | 43.78% |
Net na kita | -1.15M | -115.08% |
Net profit margin | -0.59 | -109.53% |
Kita sa bawat share | — | — |
EBITDA | 2.93M | -58.16% |
Aktuwal na % ng binabayarang buwis | 52.61% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 207.16M | 161.27% |
Kabuuang asset | 1.19B | 139.09% |
Kabuuang sagutin | 768.01M | 236.59% |
Kabuuang equity | 421.94M | — |
Natitirang share | 338.40M | — |
Presyo para makapag-book | 12.60 | — |
Return on assets | -0.12% | — |
Return on capital | -0.17% | — |
Cash Flow
Net change in cash
| (USD) | Hun 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -1.15M | -115.08% |
Cash mula sa mga operasyon | 8.87M | -54.91% |
Cash mula sa pag-invest | -129.43M | -428.60% |
Cash mula sa financing | -1.46M | -160.91% |
Net change in cash | -116.42M | -2,260.99% |
Malayang cash flow | -3.60M | -105.50% |
Tungkol
Itinatag
2015
Website
Mga Empleyado
423
